Main Article Content

Abstract

Purpose: As a result of a sudden spreading of an epidemic novel virus, scientifically named COVID-19, this paper has been done to present a contribution towards fighting this virus in Iraq. 


Methodology: This investigation is focusing on constructing an engineering mathematical model based on the Suspected, Infected, and Recovered model (SIR), given by Kermack and McKendrick. 


Main Findings: Iraqi people are facing and suffering from this COVID-19. Three governorates occupying the locally highest infection levels, plus the world's highest deaths to infected cases ratio of about 11%, are Baghdad, Sulaimani, and Karbala. 


Implications: It is showed that the Reproduction ratio R0)K is positive (greater than 1) in the three nominated zones, which means that the epidemic disease will keep spreading in a broad manner and depending on many specific factors. Many effective recommendations are presented to avoid spreading this novel virus via many techniques. 


Novelty: SIR model is used to assess epidemic levels in 3 zones. 

Keywords

Corona Virus COVID-19 Communicable Diseases Mathematical Modelling Iraq

Article Details

How to Cite
Hussein, E. K., Gaaz, T. S., Subhi, K. A., Ghouali, S., & Guellil, M. S. (2021). ENGINEERING MATHEMATICAL MODELLING OF CORONA VIRUS (COVID-19) TRANSMISSION IN IRAQ. International Journal of Students’ Research in Technology & Management, 9(3), 01-14. https://doi.org/10.18510/ijsrtm.2021.931

References

  1. Bastola, A., Sah, R., Rodriguez-Morales, A. J., Lal, B. K., Jha, R., Ojha, H. C., et al.(2020). The first 2019 novel coronavirus case in Nepal. The Lancet Infectious Diseases, 20, 279-280. https://doi.org/10.1016/S1473-3099(20)30067-0 DOI: https://doi.org/10.1016/S1473-3099(20)30067-0
  2. Cardona-Ospina, J. A., Henao-SanMartin, V., Acevedo-Mendoza, W. F., Nasner-Posso, K. M., Martínez-Pulgarín, D. F., Restrepo-López, A., et al. (2019). Fatal Zika virus infection in the Americas: A systematic review. International Journal of Infectious Diseases, 88, 49-59. https://doi.org/10.1016/j.ijid.2019.08.033 DOI: https://doi.org/10.1016/j.ijid.2019.08.033
  3. He, W., Chen, S., Liu, X., Li, Y., Xiao, Z. and Zhong, N. (2003). Death risk factors of severe acute respiratory syndrome with acute respiratory distress syndrome. Zhongguo Wei Zhong bing Ji jiu Yi xue= Chinese critical care medicine= Zhongguo weizhongbing jijiuyixue, 15, 336-337.
  4. Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H. et al. (2020). First case of 2019 novel coronavirus in the United States. New England Journal of Medicine, 382, 929-936 https://doi.org/10.1056/NEJMoa2001191 DOI: https://doi.org/10.1056/NEJMoa2001191
  5. Hui, P. Cook, D. J., Lim, W., Fraser, G. A., and Arnold, D. M.(2011). The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest, 139, 271-278. https://doi.org/10.1 378/chest.10-2243 DOI: https://doi.org/10.1378/chest.10-2243
  6. Khurana, D. and Deoke, S. A.(2017). Thrombocytopenia in critically ill patients: Clinical and laboratorial behaviour and its correlation with short-term outcome during hospitalization. Indian journal of critical care medicine: peer-reviewed, official publication of Indian Society of Critical Care Medicine, 21, 861-864. https://doi.org/10.4103/ijccm.IJCCM_279_17 DOI: https://doi.org/10.4103/ijccm.IJCCM_279_17
  7. Macrotrends (2000). https://www.macrotrends.net/cities/21529/baghdad/population.
  8. Mattiuzzi, C. and Lippi, G. (2020). Which lessons shall we learn from the 2019 novel coronavirus outbreak. Annals of Translational Medicine, 8(3), 48. https://doi.org/10.21037/atm.2020.02.06 DOI: https://doi.org/10.21037/atm.2020.02.06
  9. Mission, W. (2020). Report of the who-china joint mission on coronavirus disease 2019 (covid-19). WHO, 2020.
  10. Pongpirul, W. A., Pongpirul, K., Ratnarathon, A. C., and Prasithsirikul, W. (2020). Journey of a Thai taxi driver and novel coronavirus. New England Journal of Medicine, 382, 1067-1068. https://doi.org/10.10 56/NEJMc2001621 DOI: https://doi.org/10.1056/NEJMc2001621
  11. Shilani, H. (2000). World Health Organization. COVID-19 Outbreak Cases in Iraq.
  12. Silverstein, W. K., Stroud, L., Cleghorn, G. E. and Leis, J. A. (2020). First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumonia. The Lancet, 395(10225), 734. https://doi.org/10.101 6/S0140-6736(20)30370-6 DOI: https://doi.org/10.1016/S0140-6736(20)30370-6
  13. Stroup, D. F., Berlin, J. A., Morton, S. C., Olkin, I., Williamson, G. D., Rennie, D., et al. (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. Jama, 283, 2008-2012. https://doi.org/10 .1001/jama.283.15.2008 DOI: https://doi.org/10.1001/jama.283.15.2008
  14. Vanderschueren, S., De Weerdt, A., Malbrain, M., Vankersschaever, D., Frans, E., Wilmer, A., et al. (2000). Thrombocytopenia and prognosis in intensive care. Critical care medicine, 28, 1871-1876. https://doi.org/10 .1097/00003246-200006000-00031 DOI: https://doi.org/10.1097/00003246-200006000-00031
  15. Yang, M., Ng, M. H. and Li, C. K. (2005). Thrombocytopenia in patients with the severe acute respiratory syndrome. Hematology, 10, 101-105. https://doi.org/10.1080/10245330400026170 DOI: https://doi.org/10.1080/10245330400026170
  16. Zhao, D., Yao, F., Wang, L., Zheng, L., Gao, Y., Ye, J., et al. (2020). A comparative study on the clinical features of COVID-19 pneumonia to other pneumonia. Clinical Infectious Diseases, 71(15), 456-761. https://doi.org/10.1093/cid/ciaa247 DOI: https://doi.org/10.1093/cid/ciaa247